US Stock MarketDetailed Quotes

Avenue Therapeutics (ATXI)

Watchlist
  • 0.6600
  • +0.1100+20.00%
15min DelayClose Apr 24 11:09 ET
1.36MMarket Cap-0.06P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Avenue Therapeutics (ATXI) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
1.4M
0
0
1.4M
0
0
0
0
0
0
Operating revenue
--1.4M
--0
--0
--1.4M
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-58.43%4.69M
-40.16%955K
-77.06%724K
-60.79%1.11M
-48.62%1.91M
-22.40%11.28M
-24.68%1.6M
52.61%3.16M
-28.04%2.82M
-42.32%3.71M
Selling and administrative expenses
-21.24%3.65M
-32.30%698K
-34.02%547K
-37.41%915K
13.53%1.49M
10.98%4.64M
-9.32%1.03M
-28.60%829K
63.17%1.46M
33.74%1.32M
-General and administrative expense
-21.24%3.65M
-32.30%698K
-34.02%547K
-37.41%915K
13.53%1.49M
10.98%4.64M
-9.32%1.03M
-28.60%829K
63.17%1.46M
33.74%1.32M
Research and development costs
-84.39%1.04M
-54.51%257K
-92.39%177K
-85.89%192K
-82.82%411K
-35.87%6.65M
-42.46%565K
156.56%2.33M
-55.04%1.36M
-56.07%2.39M
Operating profit
70.88%-3.29M
40.16%-955K
77.06%-724K
110.52%297K
48.62%-1.91M
22.40%-11.28M
24.68%-1.6M
-52.61%-3.16M
28.04%-2.82M
42.32%-3.71M
Net non-operating interest income expense
-31.25%121K
4.17%25K
-33.33%34K
-40.38%31K
-34.69%32K
185.44%176K
9.09%24K
466.67%51K
-8.77%52K
116.61%49K
Non-operating interest income
-31.25%121K
4.17%25K
-33.33%34K
-40.38%31K
-34.69%32K
39.68%176K
9.09%24K
466.67%51K
-8.77%52K
32.43%49K
Non-operating interest expense
----
----
----
----
----
--0
--0
--0
--0
--0
Other net income (expense)
137.01%218K
1,469.23%204K
-111.11%-2K
-98.57%1K
102.17%15K
-113.83%-589K
-99.52%13K
-99.30%18K
146.67%70K
21.41%-690K
Gain on sale of security
102.55%15K
-92.31%1K
-111.11%-2K
-98.57%1K
102.17%15K
-113.83%-589K
-99.52%13K
-99.30%18K
146.67%70K
21.41%-690K
Special income (charges)
--203K
----
----
----
----
--0
----
----
----
----
-Gain on sale of business
--203K
----
----
----
----
--0
----
----
----
----
Income before tax
74.80%-2.95M
53.43%-726K
77.58%-692K
112.18%329K
57.28%-1.86M
-11.52%-11.7M
-352.67%-1.56M
-701.75%-3.09M
32.74%-2.7M
42.79%-4.35M
Income tax
Net income
74.80%-2.95M
53.43%-726K
77.58%-692K
112.18%329K
57.28%-1.86M
-11.52%-11.7M
-352.67%-1.56M
-701.75%-3.09M
32.74%-2.7M
42.79%-4.35M
Net income continuous Operations
74.80%-2.95M
53.43%-726K
77.58%-692K
112.18%329K
57.28%-1.86M
-11.52%-11.7M
-352.67%-1.56M
-701.75%-3.09M
32.74%-2.7M
42.79%-4.35M
Minority interest income
13.64%-38K
-13.33%-17K
18.18%-9K
33.33%-6K
33.33%-6K
60.36%-44K
34.78%-15K
15.38%-11K
0.00%-9K
86.36%-9K
Net income attributable to the parent company
75.03%-2.91M
54.08%-709K
77.80%-683K
104.66%335K
57.33%-1.85M
-12.29%-11.65M
-341.25%-1.54M
-684.79%-3.08M
-79.34%-7.19M
42.41%-4.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
75.03%-2.91M
-109.76%-709K
77.80%-683K
104.66%335K
57.33%-1.85M
-12.29%-11.65M
1,035.31%7.27M
-684.79%-3.08M
-79.34%-7.19M
42.41%-4.34M
Basic earnings per share
94.11%-0.93
-114.86%-0.22
89.06%-0.21
101.71%0.11
95.97%-0.62
78.51%-15.79
-21.07%1.48
-139.51%-1.92
83.40%-6.43
84.84%-15.4
Diluted earnings per share
94.11%-0.93
-114.86%-0.22
89.06%-0.21
101.71%0.11
95.97%-0.62
78.51%-15.79
-21.07%1.48
-139.51%-1.92
83.40%-6.43
84.84%-15.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 1.4M001.4M000000
Operating revenue --1.4M--0--0--1.4M--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -58.43%4.69M-40.16%955K-77.06%724K-60.79%1.11M-48.62%1.91M-22.40%11.28M-24.68%1.6M52.61%3.16M-28.04%2.82M-42.32%3.71M
Selling and administrative expenses -21.24%3.65M-32.30%698K-34.02%547K-37.41%915K13.53%1.49M10.98%4.64M-9.32%1.03M-28.60%829K63.17%1.46M33.74%1.32M
-General and administrative expense -21.24%3.65M-32.30%698K-34.02%547K-37.41%915K13.53%1.49M10.98%4.64M-9.32%1.03M-28.60%829K63.17%1.46M33.74%1.32M
Research and development costs -84.39%1.04M-54.51%257K-92.39%177K-85.89%192K-82.82%411K-35.87%6.65M-42.46%565K156.56%2.33M-55.04%1.36M-56.07%2.39M
Operating profit 70.88%-3.29M40.16%-955K77.06%-724K110.52%297K48.62%-1.91M22.40%-11.28M24.68%-1.6M-52.61%-3.16M28.04%-2.82M42.32%-3.71M
Net non-operating interest income expense -31.25%121K4.17%25K-33.33%34K-40.38%31K-34.69%32K185.44%176K9.09%24K466.67%51K-8.77%52K116.61%49K
Non-operating interest income -31.25%121K4.17%25K-33.33%34K-40.38%31K-34.69%32K39.68%176K9.09%24K466.67%51K-8.77%52K32.43%49K
Non-operating interest expense ----------------------0--0--0--0--0
Other net income (expense) 137.01%218K1,469.23%204K-111.11%-2K-98.57%1K102.17%15K-113.83%-589K-99.52%13K-99.30%18K146.67%70K21.41%-690K
Gain on sale of security 102.55%15K-92.31%1K-111.11%-2K-98.57%1K102.17%15K-113.83%-589K-99.52%13K-99.30%18K146.67%70K21.41%-690K
Special income (charges) --203K------------------0----------------
-Gain on sale of business --203K------------------0----------------
Income before tax 74.80%-2.95M53.43%-726K77.58%-692K112.18%329K57.28%-1.86M-11.52%-11.7M-352.67%-1.56M-701.75%-3.09M32.74%-2.7M42.79%-4.35M
Income tax
Net income 74.80%-2.95M53.43%-726K77.58%-692K112.18%329K57.28%-1.86M-11.52%-11.7M-352.67%-1.56M-701.75%-3.09M32.74%-2.7M42.79%-4.35M
Net income continuous Operations 74.80%-2.95M53.43%-726K77.58%-692K112.18%329K57.28%-1.86M-11.52%-11.7M-352.67%-1.56M-701.75%-3.09M32.74%-2.7M42.79%-4.35M
Minority interest income 13.64%-38K-13.33%-17K18.18%-9K33.33%-6K33.33%-6K60.36%-44K34.78%-15K15.38%-11K0.00%-9K86.36%-9K
Net income attributable to the parent company 75.03%-2.91M54.08%-709K77.80%-683K104.66%335K57.33%-1.85M-12.29%-11.65M-341.25%-1.54M-684.79%-3.08M-79.34%-7.19M42.41%-4.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 75.03%-2.91M-109.76%-709K77.80%-683K104.66%335K57.33%-1.85M-12.29%-11.65M1,035.31%7.27M-684.79%-3.08M-79.34%-7.19M42.41%-4.34M
Basic earnings per share 94.11%-0.93-114.86%-0.2289.06%-0.21101.71%0.1195.97%-0.6278.51%-15.79-21.07%1.48-139.51%-1.9283.40%-6.4384.84%-15.4
Diluted earnings per share 94.11%-0.93-114.86%-0.2289.06%-0.21101.71%0.1195.97%-0.6278.51%-15.79-21.07%1.48-139.51%-1.9283.40%-6.4384.84%-15.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -